
    
      The purpose of this research study is to evaluate a new method of T cell depletion using the
      Miltenyi CliniMACS™ device for patients undergoing a peripheral stem cell transplant
      utilizing either a unrelated donor or partially matched/haploidentical related donor. This
      new method is called α/β (alpha/beta) T cell depletion and CD19+ B cell depletion. This pilot
      study will evaluate if this new method of T cell and B cell depletion is a more effective way
      of removing T cells thus reducing the risk of severe acute and chronic GVHD and result in a
      durable engraftment.
    
  